Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4914)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 14, 2024 (publication date) through Mar 25, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Boldys A, Buldak L. Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration. World J Gastroenterol 2024; 30(18): 2387-2390 [PMID: 38764762 DOI: 10.3748/wjg.v30.i18.2387] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Boldys A, Buldak L. Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration. World J Gastroenterol 2024; 30(18): 2387-2390 [PMID: 38764762 DOI: 10.3748/wjg.v30.i18.2387] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i18/2387.htm |
| Number | Citing Articles |
| 1 |
Anne Brennan. Metabolic Dysfunction-Associated Steatotic Liver Disease: a rapidly growing common liver disease. Gastrointestinal Nursing 2025; 23(Sup6): S11 doi: 10.12968/gasn.2024.0120R3
|
| 2 |
Anas Hatab, Noor Gaafar Mansour , Ahmed Rabha, Rawan Abouhatab. Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Clinical and Metabolic Outcomes in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Cureus 2025; doi: 10.7759/cureus.100043
|
| 3 |
Ashraf Abbass Basuni, Dina Sweed, Mohammed Fathey Elgazzar, Ashraf Khalil. Exploring serum bile acids as potential noninvasive biomarkers for nonalcoholic fatty liver disease. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00378-9
|
| 4 |
Luigi Barrea, Ludovica Verde, Martina Galasso, Silvia Savastano, Annamaria Colao, Giovanna Muscogiuri. Very low energy ketogenic therapy: an anti-inflammatory medical nutritional approach for MASLD in obesity. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-07295-4
|
| 5 |
Silvia Chafino, Laura Tarancon-Diez, Jara Hurtado-Gallego, Marina Flores-Piñas, Sonia Alcolea, Antonio Olveira, María Luisa Navarro, Salvador Fernández-Arroyo, Consuelo Viladés, Maria Luisa Montes, Francesc Vidal, Joaquim Peraire, Anna Rull, Talía Sainz. Metabolomics for searching non-invasive biomarkers of metabolic dysfunction-associated steatotic liver disease in youth with vertical HIV. Communications Medicine 2025; 5(1) doi: 10.1038/s43856-025-01149-2
|
| 6 |
Benan Pelin Sermikli, Sihao Liu, Kyeongkyu Kim, Linnea Hases, Tim van Zutphen, Ashley Untereiner, Jocelyn Torres, Mingxiao He, Lillian Crossley, Yang Dai, Jonathan Zhu, Chandra Lekha Koopari, Weiwei Fan, Morgan L. Truitt, Johan W. Jonker, Annette R. Atkins, Michael Downes, Ronald M. Evans. FGF1 orchestrates circadian hepatic triglyceride secretion. Nature Communications 2026; doi: 10.1038/s41467-026-70849-7
|
| 7 |
Jenyfer M Fuentes-Mendoza, Marcio J Concepción-Zavaleta, Jeny J Mendoza-Godoy, Luis A Concepción-Urteaga, Carlos O Martínez-Gutiérrez, José Paz-Ibarra. Dyslipidemia in liver cirrhosis: Pathophysiology and emerging therapeutic approaches. World Journal of Hepatology 2026; 18(3): 115539 doi: 10.4254/wjh.v18.i3.115539
|
| 8 |
Diana Abu-Halaka, Einat Rauchbach, Haim Zeigerman, Oren Tirosh. DMF, an activator of Nrf2, could mitigate cholic-acid-induced liver damage in high-fat diet. Exploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.100581
|
| 9 |
Sajad Ehtiati, Roya Pakrad, Seyyed Hossein Khatami, Reza Ataei Kachouei, Alireza Doagoo, Hossein Lanjanian, Seyyed Amir Hossein Ghazizadeh Hashemi, Nastaran Hamed, Behzad Hatami, Reyhane Ahmadzade, Farzaneh Salmani, Saeed Karima. Targeting inflammatory dysregulation in metabolic dysfunction-associated steatotic liver disease rat model: the preventive and therapeutic effects of acetyl-11-keto-beta-boswellic acid. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(12): 17211 doi: 10.1007/s00210-025-04340-3
|
| 10 |
Vignesh Rajan, Ambarish Das, J. Venkatachalam, K. K. Lohani, Chandrakant Lahariya. Managing Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Primary Care Settings: A Review. Preventive Medicine: Research & Reviews 2025; 2(4): 183 doi: 10.4103/PMRR.PMRR_159_24
|
| 11 |
Ambrin Farizah Babu. Metabolic Signatures in Lean MASLD: Current Insights and Future Directions. Metabolites 2025; 15(9): 583 doi: 10.3390/metabo15090583
|
| 12 |
Jae Eun So, Jaehong Jeong, Jung Pyo Hong, Dong Yun Kim, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Hye Won Lee, Seung Up Kim. The Impact of Liraglutide on Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease. Journal of Gastroenterology and Hepatology 2025; 40(12): 2976 doi: 10.1111/jgh.70134
|
| 13 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
|
| 14 |
Jeysson E Mejia-Guzman, Francisco Fernández-Nogueira, Guadalupe Yarza-Rosas, David E González-Mendoza, José M Juárez-Sosa, Laureano Palacio-Zurita. Scientific Publications on the Association Between Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Bibliometric Study From 2010 to 2024. Cureus 2025; doi: 10.7759/cureus.90708
|
| 15 |
Cristian R. Perez, Mohamed A. Elfeki. Artificial Intelligence, Real Results: AI Successfully Risk-Stratifies Patients with MASLD. Digestive Diseases and Sciences 2026; doi: 10.1007/s10620-026-09831-8
|